Kadian Revenue Jump Offsets Alpharma's Loss Of Gabapentin Exclusivity
This article was originally published in The Pink Sheet Daily
Executive Summary
Increased sales and marketing efforts have driven the extended-release morphine's weekly prescription rates above 10,000.